ResearcherJiading District Central HospitalActive in the last 2 years

Run-Sheng Guo

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2024: 1 paper

Papers 1

Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer. Last author DOI 10.1007/s13402-023-00852-3 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Pengcheng Chen · 1 shared paper, 2024 · strength 0.22
- Paper Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer. DOI 10.1007/s13402-023-00852-3 ↗
Shu‐Heng Jiang · 1 shared paper, 2024 · strength 0.22
- Paper Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer. DOI 10.1007/s13402-023-00852-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.